Electrofisiología Cardíaca Celular

Tamargo, J; Caballero, R; Delpon, E.

New Drugs for the Treatment of Hyperkalemia in Patients Treated with Renin- Angiotensin-Aldosterone System Inhibitors - Hype or Hope?

Discovery Medicine. 2014; 18(100): 249-254 Nº de citas: 12

Gomez, R; Caballero, R; Barana, A; Amoros, I; De Palm, SH; Matamoros, M; Nunez, M; Perez-Hernandez, M; Iriepa, I; Tamargo, J; Delpon, E.

Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents

CARDIOVASCULAR RESEARCH. 2014; 104(2): 337-346 Nº de citas: 24 [doi:10.1093/cvr/cvu203]

Alfonso, F; Collet, JP; Cremer, J; Falk, V; Filippatos, G; Hamm, C; Head, SJ; Juni, P; Kappetein, AP; Kastrati, A; Landmesser, U; Laufer, G; Neumann, FJ; Richter, DJ; Schauerte, P; Stefanini, GG; Taggart, DP; Torracca, L; Valgimigli, M; Witkowski, A; Baumgartner, H; Bax, JJ; Bueno, H; Dean, V; Erol, C; Fagard, R; Ferrari, R; Hoes, AW; Knuuti, J; Kolh, P; Lancellotti, P; Linhart, A; Nihoyannopoulos, P; Piepoli, MF; Ponikowski, P; Sirnes, PA; Tamargo, JL; Tendera, M; Torbicki, A; Wijns, W; Windecker, S; Uva, MS; Achenbach, S; Pepper, J; Anyanwu, A; Badimon, L; Bauersachs, J; Baumbach, A; Beygui, F; Bonaros, N; De Carlo, M; Deaton, C; Dobrev, D; Dunning, J; Eeckhout, E; Gielen, S; Hasdai, D; Kirchhof, P; Luckraz, H; Mahrholdt, H; Montalescot, G; Paparella, D; Rastan, AJ; Sanmartin, M; Sergeant, P; Silber, S; Tamargo, J; ten Berg, J; Thiele, H; van Geuns, RJ; Wagner, HO; Wassmann, S; Wendler, O; Zamorano, JL.

2014 ESC/EACTS Guidelines on myocardial revascularization

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2014; 46(4): 517-592 Nº de citas: 15 [doi:10.1093/ejcts/ezu366]

Barana, A; Matamoros, M; Dolz-Gaiton, P; Perez-Hernandez, M; Amoros, I; Nunez, M; Sacristan, S; Pedraz, A; Pinto, A; Fernandez-Aviles, F; Tamargo, J; Delpon, E; Caballero, R.

Chronic Atrial Fibrillation Increases MicroRNA-21 in Human Atrial Myocytes Decreasing L-Type Calcium Current

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY. 2014; 7(5): 861-192 Nº de citas: 98 [doi:10.1161/CIRCEP.114.001709]

Tamargo, J; Solini, A; Ruilope, LM.

Comparison of Agents That Affect Aldosterone Action

SEMINARS IN NEPHROLOGY. 2014; 34(3): 285-306 Nº de citas: 24 [doi:10.1016/j.semnephrol.2014.04.005]

Dolz-Gaiton, P; Nunez, M; Nunez, L; Barana, A; Amoros, I; Matamoros, M; Perez-Hernandez, M; de la Fuente, MG; Alvarez-Lopez, M; Macias-Ruiz, R; Tercedor-Sanchez, L; Jimenez-Jaimez, J; Delpon, E; Caballero, R; Tamargo, J.

Functional Characterization of a Novel Frameshift Mutation in the C-terminus of the Nav1.5 Channel Underlying a Brugada Syndrome with Variable Expression in a Spanish Family

PLoS One. 2013; 8(11): Nº de citas: 18 [doi:10.1371/journal.pone.0081493]

Amoros, I; Dolz-Gaiton, P; Gomez, R; Matamoros, M; Barana, A; de la Fuente, MG; Nunez, M; Perez-Hernandez, M; Moraleda, I; Galvez, E; Iriepa, I; Tamargo, J; Caballero, R; Delpon, E.

Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore

BIOCHEMICAL PHARMACOLOGY. 2013; 86(2): 267-278 Nº de citas: 17 [doi:10.1016/j.bcp.2013.04.023]

de la Fuente, MG; Barana, A; Gomez, R; Amoros, I; Dolz-Gaiton, P; Sacristan, S; Atienza, F; Pita, A; Pinto, A; Fernandez-Aviles, F; Caballero, R; Tamargo, J; Delpon, E.

Chronic atrial fibrillation up-regulates 1-Adrenoceptors affecting repolarizing currents and action potential duration

CARDIOVASCULAR RESEARCH. 2013; 97(2): 379-388 Nº de citas: 37 [doi:10.1093/cvr/cvs313]

Nunez, L; Barana, A; Amoros, I; de la Fuente, MG; Dolz-Gaiton, P; Gomez, R; Rodriguez-Garcia, I; Mosquera, I; Monserrat, L; Delpon, E; Caballero, R; Castro-Beiras, A; Tamargo, J.

p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient

HEART RHYTHM. 2013; 10(2): 264-272 Nº de citas: 34 [doi:10.1016/j.hrthm.2012.10.025]

Tamargo, J; Caballero, R; Delpon, E.

Drug-induced Atrial Fibrillation: Does It Matter?

Discovery Medicine. 2012; 14(78): 295-299 Nº de citas: 12

Tamargo, J; Caballero, R; Delpon, E.

Drug-induced atrial fibrillation

EXPERT OPINION ON DRUG SAFETY. 2012; 11(4): 615-634 Nº de citas: 23 [doi:10.1517/14740338.2012.698609]

Gomez-Guzman, M; Jimenez, R; Sanchez, M; Romero, M; O'Valle, F; Lopez-Sepulveda, R; Quintela, AM; Galindo, P; Zarzuelo, MJ; Bailon, E; Delpon, E; Perez-Vizcaino, F; Duarte, J.

Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats

BRITISH JOURNAL OF NUTRITION. 2011; 106(9): 1337-1348 Nº de citas: 57 [doi:10.1017/S0007114511004314]

Chinchilla, A; Daimi, H; Lozano-Velasco, E; Dominguez, JN; Caballero, R; Delpon, E; Tamargo, J; Cinca, J; Hove-Madsen, L; Aranega, AE; Franco, D.

PITX2 Insufficiency Leads to Atrial Electrical and Structural Remodeling Linked to Arrhythmogenesis

Circulation-Cardiovascular Genetics. 2011; 4(3): 269-133 Nº de citas: 220 [doi:10.1161/CIRCGENETICS.110.958116]

Amoros, I; Jimenez-Jaimez, J; Tercedor, L; Barana, A; Gomez, R; de la Fuente, MG; Dolz-Gaiton, P; Alvarez, M; Martinez-Espin, E; Lorente, JA; Melgares, R; Tamargo, J; Delpon, E; Caballero, R.

Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome

HEART RHYTHM. 2011; 8(3): 463-470 Nº de citas: 7 [doi:10.1016/j.hrthm.2010.11.032]

Tamargo, J; Lopez-Farre, A; Caballero, R; Delpon, E.

DRONEDARONE

DRUGS TODAY. 2011; 47(2): 109-133 Nº de citas: 3 [doi:10.1358/dot.2011.47.2.1545699]